ZS · Investment summary · as of 3 August 2026
Priced for an operating path the record does not support
Business type: Inflection · scaling but economically observable
The business does not meet the quality standard for its economic type.
At $154.46, ZS requires a 0% five-year revenue growth rate to justify its enterprise value — less than the business already delivers, at 25%.
The market prices ZS on non-GAAP margin (23.0%) and FCF (28.1%); GAAP OM is -4.73% with SBC at 24.67% of revenue. Whether the price is achievable turns on the GAAP terminal margin (the SBC wedge closing), not on growth - the growth axis carries +21..+24pp of slack at the C1 anchors.
The value rests on an exit multiple of 10.5x, a terminal operating margin of 15% and a 9.7% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.
The strongest argument against this view: New-logo acquisition failure compounding through the sales-leadership transition while PANW's platform bundle takes the greenfield; growth decelerates through the guide toward ~10% and the multiple settles at the 2026-window floor.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | The market prices ZS on non-GAAP margin (23.0%) and FCF (28.1%); GAAP OM is -4.73% with SBC at 24.67% of revenue. |
| What do we forecast? | Revenue growth of 25% demonstrated; a terminal operating margin of 15%; an exit multiple of 10.5x. |
| What does Street forecast? | Not determined — no consensus estimates are joined to this record |
| Where do we differ? | On terminal margin, the difference between what the price requires and what the business has demonstrated is -27.1 percentage points. |
| What is it worth? | Twelve-month target $173.02, +12% from the struck price. Scenario-weighted expected return net of costs +12.0%. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
| Date or window | Event | Thesis confirmed if | Thesis weakened or refuted if |
|---|---|---|---|
| FQ4 FY26 print | FY27 formal guidance (early Sept 2026) below 16% revenue/ARR growth | FY27 formal guidance (early Sept 2026) at or above 16% revenue/ARR growth | FY27 formal guidance (early Sept 2026) below 16% revenue/ARR growth |
| quarterly | Organic net-new ARR growth (ex-Red Canary) turns <= 0 | Neither leg of the condition opposite is met at this date | Organic net-new ARR growth (ex-Red Canary) turns <= 0 |
| quarterly | NRR prints below 110% (last 115%) | NRR prints at or above 110% (last 115%) | NRR prints below 110% (last 115%) |
| quarterly | Total RPO growth falls below revenue growth (now +29.8% vs +24.6%) | Neither leg of the condition opposite is met at this date | Total RPO growth falls below revenue growth (now +29.8% vs +24.6%) |
New-logo acquisition failure compounding through the sales-leadership transition while PANW's platform bundle takes the greenfield; growth decelerates through the guide toward ~10% and the multiple settles at the 2026-window floor. Management's own evidence: two sales-leadership departures at end-FQ3 FY26, guidance made 'prudent... during this transition', CFO named new logos as underperforming, FY27 guided 16-17% from 25%.
Estimated probability 10%, against the 31% level at which the position would be resized. It sits within that level.
Falsifiable and fundamental — not one of them is a price condition.
Trim/exit on valuation and opportunity cost if the multiple re-rates through the 2026 window's p75 (~$204, +32%) without a raised FY27 guide; at the $173 base target forward E[R] compresses toward zero with the September guide still ahead - reassess there. On approach to the $173.02 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Not met | Is the business worth owning under its declared economic type? |
| Valuation | Not met | Is the operating path required by today's price achievable? |
| Liquidity | Met | Can the intended position be built and exited in the right vehicle? |
| Downside | Met | New-logo acquisition failure compounding through the sales-leadership transition while PANW's platform bundle takes the greenfield; growth decelerates through the guide toward ~10% and the multiple settles at the 2026-window floor. |
| Momentum | Not determined | Does price action support or complicate entry timing? Not established on the evidence on file. |
| Catalyst | Not determined | Is there a dated event that resolves the disagreement? Not established on the evidence on file. |
| Consensus | Not determined | Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The gap between what today's price requires and what the business has demonstrated is -27.1 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is the permanent-loss mechanism: new-logo acquisition failure compounding through the sales-leadership transition while PANW's platform bundle takes the greenfield; growth decelerates through the guide toward ~10% and the multiple settles at the 2026-window floor. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $132.56, which forces an immediate review.